HomeREKA • TLV
add
Rekah Pharmaceutical Industry Ltd
Previous close
ILA 1,167.00
Year range
ILA 1,044.00 - ILA 1,498.00
Market cap
134.48M ILS
Avg Volume
2.72K
P/E ratio
-
Dividend yield
-
Primary exchange
TLV
Market news
Financials
Income Statement
Revenue
Net income
| (ILS) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 75.07M | -13.90% |
Operating expense | 19.88M | -1.39% |
Net income | -5.33M | -13.97% |
Net profit margin | -7.09 | -32.28% |
Earnings per share | — | — |
EBITDA | 4.66M | 13.20% |
Effective tax rate | -16.82% | — |
Balance Sheet
Total assets
Total liabilities
| (ILS) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.06M | 63.23% |
Total assets | 414.67M | -8.73% |
Total liabilities | 264.28M | -8.86% |
Total equity | 150.39M | — |
Shares outstanding | 11.10M | — |
Price to book | 0.86 | — |
Return on assets | -1.72% | — |
Return on capital | -2.49% | — |
Cash Flow
Net change in cash
| (ILS) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -5.33M | -13.97% |
Cash from operations | 3.92M | 150.66% |
Cash from investing | -1.31M | 50.75% |
Cash from financing | 491.00K | -94.32% |
Net change in cash | 3.10M | 278.55% |
Free cash flow | 4.79M | 167.52% |
About
Founded
1947
Website
Employees
421
